Sepsis is one of the most prevalent conditions in critical care medicine and is characterized by a high incidence, mortality, and poor prognosis, with no specific treatment currently available. The pathogenesis of sepsis is complex with a dysregulated inflammatory response at its core. If the initial inflammatory response is not promptly controlled, patients often develop multiple organ dysfunction syndrome or die, whereas survivors may experience post-sepsis syndrome. Regulation by the central and autonomic nervous systems is essential for maintaining inflammatory homeostasis. Among these, the cholinergic anti-inflammatory pathway (CAP) has been extensively studied in sepsis owing to its significant role in modulating inflammatory responses. Recent advancements in CAP-related interventions include minimally invasive vagus nerve stimulation, novel α7nAchR-targeting drugs, serum choline acetyltransferase and cholinesterase, acupuncture, and focused ultrasound stimulation therapy. This review primarily discusses the advantages, limitations, and therapeutic prospects of these approaches. Additionally, heart rate variability, which reflects changes in autonomic nervous system function, can serve as an indicator for assessing the functional status of the vagus nerve. In summary, modulation of inflammatory responses through the vagus nerve-mediated CAP represents a potential strategy for achieving precision medicine for sepsis. Future research should focus on conducting high-quality clinical studies on CAP-based therapies in the context of sepsis-induced inflammatory dysregulation. Incorporating indicators to evaluate the autonomic nervous system function may further elucidate the impact of inflammatory dysregulation in the body.
SingerMDeutschmanCSSeymourCW, et al.The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801.
2.
KaukonenKMBaileyMSuzukiSPilcherDBellomoR. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311(13):1308–1316.
3.
Shankar-HariMPhillipsGSLevyML, et al.Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):775–787.
4.
RuddKEJohnsonSCAgesaKM, et al.Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the global burden of disease study. Lancet. 2020 Jan 18;395(10219):200–211.
5.
BauerMGerlachHVogelmannT, et al.Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care. 2020 May 19;24(1):239.
6.
PaoliCJReynoldsMASinhaM, et al.Epidemiology and costs of sepsis in the United States-an analysis based on timing of diagnosis and severity level. Crit Care Med. 2018 Dec;46(12):1889–1897.
7.
Giamarellos-BourboulisEJAschenbrennerACBauerM, et al.The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024 Jan;25(1):19–28.
8.
HuangMCaiSSuJ. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019 Oct 29;20(21):5376.
9.
RaymondSLHoldenDCMiraJC, et al.Microbial recognition and danger signals in sepsis and trauma. Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt B):2564–2573.
10.
DobsonGPLetsonHLMorrisJL. Revolution in sepsis: A symptoms-based to a systems-based approach?J Biomed Sci. 2024 May 30;31(1):57.
11.
TimmermansKKoxMVanekerM, et al.Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med. 2016 Apr;42(4):551–561.
12.
HotchkissRSMonneretGPayenD. Immunosuppression in sepsis: A novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013 Mar;13(3):260–268.
13.
CavaillonJM. During sepsis and COVID-19, the pro-inflammatory and anti-inflammatory responses are concomitant. Clin Rev Allergy Immunol. 2023 Oct;65(2):183–187.
Van der PollTShankar-HariMWiersingaWJ. The immunology of sepsis. Immunity. 2021 Nov 9;54(11):2450–2464.
16.
IbaTLevyJH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Anesthesiology. 2020 May;132(5):1238–1245.
17.
ARDS Definition Task Force, RanieriVMRubenfeldGD, et al.Acute respiratory distress syndrome: The Berlin definition. JAMA. 2012 Jun 20;307(23):2526–2533.
18.
ZarbockANadimMKPickkersP, et al.Sepsis-associated acute kidney injury: Consensus report of the 28th acute disease quality initiative workgroup. Nat Rev Nephrol. 2023 Jun;19(6):401–417.
19.
CaoCYuMChaiY. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis. Cell Death Dis. 2019 Oct 14;10(10):782.
20.
MostelZPerlAMarckM, et al.Post-sepsis syndrome - an evolving entity that afflicts survivors of sepsis. Mol Med. 2019 Dec 31;26(1):6.
21.
Van der SlikkeECAnAYHancockREW, et al.Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities. EBioMedicine. 2020 Nov;61:103044. doi: https://doi.org/10.1016/j.ebiom.2020.103044.
22.
AngusDCOpalS. Immunosuppression and secondary infection in sepsis: Part, not all, of the story. JAMA. 2016 Apr 12;315(14):1457–1459.
23.
PrescottHCOsterholzerJJLangaKM, et al.Late mortality after sepsis: Propensity matched cohort study. Br Med J.2016 May 17;353:i2375. doi: https://doi.org/10.1136/bmj.i2375.
24.
CarraraMFerrarioMBollen PintoB, et al.The autonomic nervous system in septic shock and its role as a future therapeutic target: A narrative review. Ann Intensive Care. 2021 May 17;11(1):80.
25.
SchmittingerCATorgersenCLucknerG, et al.Adverse cardiac events during catecholamine vasopressor therapy: A prospective observational study. Intensive Care Med. 2012 Jun;38(6):950–958.
26.
HollenbergSMSingerM. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021 Jun;18(6):424–434.
27.
RudigerASingerM. Decatecholaminisation during sepsis. Crit Care. 2016 Oct 4;20(1):309.
28.
TraceyKJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007 Feb;117(2):289–296.
29.
JinHLiMJeongE, et al.A body-brain circuit that regulates body inflammatory responses. Nature. 2024 Jun;630(8017):695–703.
30.
lenNV. The cholinergic anti-inflammatory pathway in humans: State-of-the-art review and future directions. Neurosci Biobehav Rev. 2022 May;136:104622. doi: https://doi.org/10.1016/j.neubiorev.2022.104622.
31.
RenCYaoRQZhangH, et al.Sepsis-associated encephalopathy: A vicious cycle of immunosuppression. J Neuroinflammation. 2020 Jan 10;17(1):14.
32.
VenetFMonneretG. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018 Feb;14(2):121–137.
33.
BorovikovaLVIvanovaSZhangM, et al.Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000 May 25;405(6785):458–462.
34.
TraceyKJ. The inflammatory reflex. Nature. 2002 Dec 19‐26;420(6917):853–859.
35.
BassiGSKanashiroACoimbraNC, et al.Anatomical and clinical implications of vagal modulation of the spleen. Neurosci Biobehav Rev. 2020 May;112:363–373. doi: https://doi.org/10.1016/j.neubiorev.2020.02.011.
36.
McKinleyMJMartelliDTrevizan-BaúP, et al.Divergent splanchnic sympathetic efferent nerve pathways regulate interleukin-10 and tumour necrosis factor-α responses to endotoxaemia. J Physiol. 2022 Oct;600(20):4521–4536.
37.
Rosas-BallinaMOlofssonPSOchaniM, et al.Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011 Oct 7;334(6052):98–101.
38.
VidaGPeñaGKanashiroA, et al.β2-Adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system. FASEB J. 2011 Dec;25(12):4476–4485.
39.
WangHYuMOchaniM, et al.Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003 Jan 23;421(6921):384–388.
40.
WangWXuHLinH, et al.The role of the cholinergic anti-inflammatory pathway in septic cardiomyopathy. Int Immunopharmacol. 2021 Jan;90:107160. doi: https://doi.org/10.1016/j.intimp.2020.107160.
41.
WangYZhanGCaiZ, et al.Vagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms. Neurosci Biobehav Rev. 2021 Aug;127:37–53. doi: https://doi.org/10.1016/j.neubiorev.2021.04.018.
42.
ZhangHCaoXYWangLN, et al.Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson's disease: A pilot randomized study. CNS Neurosci Ther. 2023 Dec;29(12):3889–3900.
43.
D'HaensGEberhardsonMCabrijanZ, et al.Neuroimmune modulation through Vagus nerve stimulation reduces inflammatory activity in crohn's disease patients: A prospective open-label study. J Crohns Colitis. 2023 Dec 30;17(12):1897–1909.
44.
KohoutovaMHorakJJarkovskaD, et al.Vagus nerve stimulation attenuates multiple organ dysfunction in resuscitated porcine progressive sepsis. Crit Care Med. 2019 Jun;47(6):e461–e469.
45.
KoxMvan EijkLTVerhaakT, et al.Transvenous vagus nerve stimulation does not modulate the innate immune response during experimental human endotoxemia: A randomized controlled study. Arthritis Res Ther. 2015 Jun 7;17(1):150.
46.
Ben-MenachemEReveszDSimonBJ, et al.Surgically implanted and non-invasive vagus nerve stimulation: A review of efficacy, safety and tolerability. Eur J Neurol. 2015 Sep;22(9):1260–1268.
47.
HuffmanWJSubramaniyanSRodriguizRM, et al.Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice. Brain Stimul. 2019 Jan‐Feb;12(1):19–29.
48.
ZouNZhouQZhangY, et al.Transcutaneous auricular vagus nerve stimulation as a novel therapy connecting the central and peripheral systems: A review. Int J Surg. 2024 Aug 1;110(8):4993–5006.
49.
WuZZhangXCaiT, et al.Transcutaneous auricular vagus nerve stimulation reduces cytokine production in sepsis: An open double-blind, sham-controlled, pilot study. Brain Stimul. 2023 Mar‐Apr;16(2):507–514.
50.
KresselAMTsaavaTLevineYA, et al.Identification of a brainstem locus that inhibits tumor necrosis factor. Proc Natl Acad Sci U S A. 2020 Nov 24;117(47):29803–29810.
51.
FalveyAPalandiraSPChavanSS, et al.Electrical stimulation of the dorsal motor nucleus of the vagus in male mice can regulate inflammation without affecting the heart rate. Brain Behav Immun. 2024 Aug;120:630–639. doi: https://doi.org/10.1016/j.bbi.2024.04.027.
52.
SchiweckCSausmekatSZhaoT, et al.No consistent evidence for the anti-inflammatory effect of vagus nerve stimulation in humans: A systematic review and meta-analysis. Brain Behav Immun. 2024 Feb;116:237–258. doi: https://doi.org/10.1016/j.bbi.2023.12.008.
53.
CedilloJLArnalichFMartín-SánchezC, et al.Usefulness of α7 nicotinic receptor messenger RNA levels in peripheral blood mononuclear cells as a marker for cholinergic antiinflammatory pathway activity in septic patients: Results of a pilot study. J Infect Dis. 2015 Jan 1;211(1):146–155.
54.
HurstRRollemaHBertrandD. Nicotinic acetylcholine receptors: From basic science to therapeutics. Pharmacol Ther. 2013 Jan;137(1):22–54.
55.
HoferSEisenbachCLukicIK, et al.Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med. 2008 Feb;36(2):404–408.
56.
WangHLiaoHOchaniM, et al.Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004 Nov;10(11):1216–1221.
57.
HustonJMOchaniMRosas-BallinaM, et al.Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med. 2006 Jul 10;203(7):1623–1628.
58.
Van WesterlooDJGiebelenIAFlorquinS, et al.The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis. 2005 Jun 15;191(12):2138–2148.
59.
AbbaspourSFahanik-BabaeiJAdeliS, et al.Acute nicotine exposure attenuates neurological deficits, ischemic injury and brain inflammatory responses and restores hippocampal long-term potentiation in ischemic stroke followed by lipopolysaccharide-induced sepsis-like state. Exp Neurol. 2024 Dec;382:114946. doi: https://doi.org/10.1016/j.expneurol.2024.114946.
60.
BolandCColletVLaterreE, et al.Electrical vagus nerve stimulation and nicotine effects in peritonitis-induced acute lung injury in rats. Inflammation. 2011 Feb;34(1):29–35.
61.
Van WesterlooDJGiebelenIAFlorquinS, et al.The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis. 2005 Jun 15;191(12):2138–2148.
62.
PatelHMcIntireJRyanS, et al.Anti-inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-κB pathway and activation of the Nrf2 pathway. J Neuroinflammation. 2017 Sep 26;14(1):192.
63.
PavlovVAOchaniMYangLH, et al.Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med. 2007 Apr;35(4):1139–1144.
64.
WuXJYanXTYangXM, et al.GTS-21 ameliorates polymicrobial sepsis-induced hepatic injury by modulating autophagy through α7nAchRs in mice. Cytokine. 2020 Apr;128:155019. doi: https://doi.org/10.1016/j.cyto.2020.155019.
65.
KongWKangKGaoY, et al.GTS-21 Protected against LPS-induced sepsis myocardial injury in mice through α7nAChR. Inflammation. 2018 Jun;41(3):1073–1083.
66.
SitaparaRAGauthierAGValdés-FerrerSI, et al.The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation. Mol Med. 2020 Jun 29;26(1):63.
67.
YangAWuCHMatsuoS, et al.Activation of the α7nAChR by GTS-21 mitigates septic tubular cell injury and modulates macrophage infiltration. Int Immunopharmacol. 2024 Sep 10;138:112555. doi: https://doi.org/10.1016/j.intimp.2024.112555.
68.
KeeverKRYakubenkoVPHooverDB. Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: Role of α7 nicotinic acetylcholine receptors. Pharmacol Res. 2023 May;191:106758. doi: https://doi.org/10.1016/j.phrs.2023.106758.
MizrachiTMarshaOBrusinK, et al.Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107. J Neuroinflammation. 2021 Apr 26;18(1):99.
ZivkovicARDeckerSOZirnsteinAC, et al.A sustained reduction in Serum cholinesterase enzyme activity predicts patient outcome following sepsis. Mediators Inflamm. 2018 Apr 29;2018:1942193. doi: https://doi.org/10.1155/2018/1942193.
74.
NeuCEsper TremlRBaumbachP, et al.Cholinesterase activities and sepsis-associated encephalopathy in viral versus nonviral sepsis. Can J Anaesth. 2024 Mar;71(3):378–389.
75.
ReardonCDuncanGSBrüstleA, et al.Lymphocyte-derived ACh regulates local innate but not adaptive immunity. Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1410–1415.
76.
ZivkovicARBenderJBrennerT, et al.Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response. J Inflamm Res. 2016 Nov 18;9:221–230. doi: https://doi.org/10.2147/JIR.S117590. Erratum in: J Inflamm Res. 2017 Mar 16;10:17.
77.
SchneiderMSchwerdtfegerA. Autonomic dysfunction in posttraumatic stress disorder indexed by heart rate variability: A meta-analysis. Psychol Med. 2020 Sep;50(12):1937–1948.
78.
SchmidtHMüller-WerdanUHoffmannT, et al.Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med. 2005 Sep;33(9):1994–2002.
79.
van WijkRJQuintenVMvan RossumMC, et al.Predicting deterioration of patients with early sepsis at the emergency department using continuous heart rate variability analysis: A model-based approach. Scand J Trauma Resusc Emerg Med. 2023 Apr 1;31(1):15.
80.
SolimanMMMarshallCKimballJP, et al.Parsimonious waveform-derived features consisting of pulse arrival time and heart rate variability predicts the onset of septic shock. Biomed Signal Process Control. 2024 Jun;92:105974. doi: https://doi.org/10.1016/j.bspc.2024.105974.
81.
YangLZhouDCaoJ, et al.Revealing the biological mechanism of acupuncture in alleviating excessive inflammatory responses and organ damage in sepsis: A systematic review. Front Immunol. 2023 Sep 11;14:1242640. doi: https://doi.org/10.3389/fimmu.2023.1242640.
82.
JiaKWuJLiuG, et al.Research progress of acupuncture and moxibustion in the treatment of sepsis based on cholinergic anti-inflammatory pathway. China J Tradit Chin Med Pharm. 2022;37(8):4277–4280.
83.
ShiYChenCChenY, et al.Research progress of the mechanism of acupuncture in the treatment of sepsis. China J Tradit Chin Med Pharm. 2021;36(12):7222–7226.
84.
ZhouYWangKYongY, et al.Research advances in the impact of immune dysfunction in sepsis and acupuncture against sepsis. Shanghai J Acupuncture Moxibustion. 2019;38(6):692–698.
85.
FanZDouBLiY, et al.Exploration of the neuro-immune regulation mechanism of acupuncture anti-inflammation. China J Tradit Chin Med Pharm. 2024;39(3):1379–1383.
86.
ZhangJChenBHuX, et al.Progress of research on organ protection of acupuncture and moxibustion in the prevention and treatment of sepsis. Acupuncture Res. 2023;48(11):1159–1167.
87.
ZhouTQianFHuangX, et al.Study on the rules of traditional Chinese medicine and acupuncture diagnosis and treatment of acute gastrointestinal injury in critically ill patients based on data mining. Modernization of Tradit Chin Medi Materia Medica-World Sci Technol. 2019;21(8):1606–1614.
88.
SunYPeiYChenM, et al.Clinical study on the application of electroacupuncture in the intervention of acute gastrointestinal injury in patients with sepsis based on the theory of Qi ascending and descending. J Emerg Tradit Chin Med. 2024;33(7):1178–1182.
89.
LiNYuHChenY, et al.Discussion on possible mechanism of acupuncture in regulating sepsis-related coagulation disorder. China J Trad Chin Med Pharm. 2022;37(8):4281–4284.
90.
LinWYangFZhangY, et al.Effect of “Tongdu Tiaoshen” needling on cognitive dysfunction in patients with sepsis asso- ciated encephalopathy and its mechanism. Acupuncture Res. 2019;44(12):888–892.
91.
ZhengSZhaoFLuoY, et al.Clinical effect of electroacupuncture at Baihui and Shuigou points in the treatment of brain injury in patients with sepsis-associated encephalopathy. Acupuncture Res. 2020;45(5):402–406.
92.
ZachsDPOffuttSJGrahamRS, et al.Noninvasive ultrasound stimulation of the spleen to treat inflammatory arthritis. Nat Commun. 2019 Mar 12;10(1):951.
93.
AhmedUGrafJFDaytzA, et al.Ultrasound neuromodulation of the spleen has time-dependent anti-inflammatory effect in a pneumonia model. Front Immunol. 2022 Jun 16;13:892086. doi: https://doi.org/10.3389/fimmu.2022.892086.
94.
ZanosSNtiloudiDPelleritoJ, et al.Focused ultrasound neuromodulation of the spleen activates an anti-inflammatory response in humans. Brain Stimul. 2023 May‐Jun;16(3):703–711.
95.
PuleoCCoteroV. Noninvasive neuromodulation of peripheral nerve pathways using ultrasound and its current therapeutic implications. Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a034215.
96.
WangFXuePWangJ, et al.Esmolol upregulates the α7 nAChR/STAT3/NF-κB pathway by decreasing the ubiquitin and increasing the ChAT + CD4+ T lymphocyte to alleviate inflammation in septic cardiomyopathy. Int Immunopharmacol. 2025 Feb 20;148:114043. doi: https://doi.org/10.1016/j.intimp.2025.114043.
97.
MasloveDMTangBShankar-HariM, et al.Redefining critical illness. Nat Med. 2022 Jun;28(6):1141–1148.
